314 related articles for article (PubMed ID: 27597935)
1. Colorectal Cancer Screening in Average Risk Populations: Evidence Summary.
Tinmouth J; Vella ET; Baxter NN; Dubé C; Gould M; Hey A; Ismaila N; McCurdy BR; Paszat L
Can J Gastroenterol Hepatol; 2016; 2016():2878149. PubMed ID: 27597935
[TBL] [Abstract][Full Text] [Related]
2. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
3. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Lin JS; Perdue LA; Henrikson NB; Bean SI; Blasi PR
JAMA; 2021 May; 325(19):1978-1998. PubMed ID: 34003220
[TBL] [Abstract][Full Text] [Related]
4. Evidence for colorectal cancer screening.
Bretthauer M
Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):417-25. PubMed ID: 20833346
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Screening Modalities in Colorectal Cancer: A Network Meta-Analysis.
Zhang J; Cheng Z; Ma Y; He C; Lu Y; Zhao Y; Chang X; Zhang Y; Bai Y; Cheng N
Clin Colorectal Cancer; 2017 Dec; 16(4):252-263. PubMed ID: 28687458
[TBL] [Abstract][Full Text] [Related]
6. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.
Singal AG; Corley DA; Kamineni A; Garcia M; Zheng Y; Doria-Rose PV; Quinn VP; Jensen CD; Chubak J; Tiro J; Doubeni CA; Ghai NR; Skinner CS; Wernli K; Halm EA
Am J Gastroenterol; 2018 May; 113(5):746-754. PubMed ID: 29487413
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
Sharaf RN; Ladabaum U
Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study.
Buskermolen M; Cenin DR; Helsingen LM; Guyatt G; Vandvik PO; Haug U; Bretthauer M; Lansdorp-Vogelaar I
BMJ; 2019 Oct; 367():l5383. PubMed ID: 31578177
[TBL] [Abstract][Full Text] [Related]
9. Screening for Colorectal Cancer: A Systematic Review and Meta-Analysis.
Fitzpatrick-Lewis D; Ali MU; Warren R; Kenny M; Sherifali D; Raina P
Clin Colorectal Cancer; 2016 Dec; 15(4):298-313. PubMed ID: 27133893
[TBL] [Abstract][Full Text] [Related]
10. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
11. Options for screening for colorectal cancer.
Atkin W
Scand J Gastroenterol Suppl; 2003; (237):13-6. PubMed ID: 12797674
[TBL] [Abstract][Full Text] [Related]
12. Comparing the effectiveness of competing tests for reducing colorectal cancer mortality: a network meta-analysis.
Elmunzer BJ; Singal AG; Sussman JB; Deshpande AR; Sussman DA; Conte ML; Dwamena BA; Rogers MA; Schoenfeld PS; Inadomi JM; Saini SD; Waljee AK
Gastrointest Endosc; 2015 Mar; 81(3):700-709.e3. PubMed ID: 25708757
[TBL] [Abstract][Full Text] [Related]
13. Interval Colorectal Cancers following Guaiac Fecal Occult Blood Testing in the Ontario ColonCancerCheck Program.
Paszat L; Sutradhar R; Tinmouth J; Baxter N; Rabeneck L
Can J Gastroenterol Hepatol; 2016; 2016():4768728. PubMed ID: 27446842
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline.
Helsingen LM; Vandvik PO; Jodal HC; Agoritsas T; Lytvyn L; Anderson JC; Auer R; Murphy SB; Almadi MA; Corley DA; Quinlan C; Fuchs JM; McKinnon A; Qaseem A; Heen AF; Siemieniuk RAC; Kalager M; Usher-Smith JA; Lansdorp-Vogelaar I; Bretthauer M; Guyatt G
BMJ; 2019 Oct; 367():l5515. PubMed ID: 31578196
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer screening.
Bretthauer M
J Intern Med; 2011 Aug; 270(2):87-98. PubMed ID: 21575082
[TBL] [Abstract][Full Text] [Related]
17. Screening and primary prevention of colorectal cancer: a review of sex-specific and site-specific differences.
Massat NJ; Moss SM; Halloran SP; Duffy SW
J Med Screen; 2013; 20(3):125-48. PubMed ID: 24197771
[TBL] [Abstract][Full Text] [Related]
18. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
19. Preventing colorectal cancer or early diagnosis: Which is best? A re-analysis of the U.S. Preventive Services Task Force Evidence Report.
Swartz AW; Eberth JM; Strayer SM
Prev Med; 2019 Jan; 118():104-112. PubMed ID: 30367971
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
